<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">101265833</journal-id>
<journal-id journal-id-type="pubmed-jr-id">33023</journal-id>
<journal-id journal-id-type="nlm-ta">Biotechnol J</journal-id>
<journal-id journal-id-type="iso-abbrev">Biotechnol J</journal-id>
<journal-title-group>
<journal-title>Biotechnology journal</journal-title>
</journal-title-group>
<issn pub-type="ppub">1860-6768</issn>
<issn pub-type="epub">1860-7314</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28976641</article-id>
<article-id pub-id-type="pmc">5882594</article-id>
<article-id pub-id-type="doi">10.1002/biot.201700159</article-id>
<article-id pub-id-type="manuscript">NIHMS945495</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Synthetic biology and the gut microbiome</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Dou</surname>
<given-names>Jennifer</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bennett</surname>
<given-names>Matthew R.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="author-notes" rid="FN1">*</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>Department of Biosciences, Rice University, Houston, TX 77005</aff>
<aff id="A2">
<label>2</label>Department of Bioengineering, Rice University, Houston, TX 77005</aff>
<author-notes>
<corresp id="FN1"><bold>Correspondence:</bold> Matthew R. Bennett, Department of Biosciences, Rice University, 6100 Main Street, Houston, TX 77005, USA, <email>matthew.bennett@rice.edu</email></corresp>
<fn fn-type="COI-statement" id="FN2">
<p id="P35">
<bold>Conflicts of interest</bold>
</p>
<p id="P36">The authors declare no financial or commercial conflicts of interest.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>28</day>
<month>2</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>27</day>
<month>10</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="ppub">
<month>5</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>5</month>
<year>2019</year>
</pub-date>
<volume>13</volume>
<issue>5</issue>
<fpage>e1700159</fpage>
<lpage>e1700159</lpage>
<!--elocation-id from pubmed: 10.1002/biot.201700159-->
<abstract>
<p id="P1">The gut microbiome plays a crucial role in maintaining human health. Functions performed by gastrointestinal microbes range from regulating metabolism to modulating immune and nervous system development. Scientists have attempted to exploit this importance through the development of engineered probiotics that are capable of producing and delivering small molecule therapeutics within the gut. However, existing synthetic probiotics are simplistic and fail to replicate the complexity and adaptability of native homeostatic mechanisms. In this review, we discuss the ways in which the tools and approaches of synthetic biology have been applied to improve the efficacy of therapeutic probiotics, and the ways in which they might be applied in the future. Simple devices, such as a bistable switches and integrase memory arrays, have been successfully implemented in the mammalian gut, and models for targeted delivery in this environment have also been developed. In the future, it will be necessary to introduce concepts such as logic-gating and biocontainment mechanisms into synthetic probiotics, as well as to expand the collection of relevant biosensors. Ideally, this will bring us closer to a reality in which engineered therapeutic microbes will be able to accurately diagnose and effectively respond to a variety of disease states.</p>
</abstract>
<kwd-group>
<kwd>biosensors</kwd>
<kwd>engineered microbes</kwd>
<kwd>microbiome therapeutics</kwd>
<kwd>engineered probiotics</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>